文献速递青光眼

青光眼中的快速进展者:基于整体与中心视野丢失的患病率

Fast Progressors in Glaucoma: Prevalence Based on Global and Central Visual Field Loss.
PubMed 文献 · Ophthalmology · 2023-01-21

本研究纳入澳大利亚墨尔本一家私人眼科诊所及美国3个中心2项前瞻性纵向观察研究的693只青光眼患眼,随访中位数4.5年,用普通最小二乘回归计算整体平均偏差(MD)与中心10°内12个测试点的平均总偏差(MTD10)变化速率,发现分别有12.5%和11.7%的患眼MD与MTD10年变化率低于-1.0 dB/年,29.0%的患眼MTD10年变化率低于-0.5 dB/年。

要点

  • 基于MD,12.5%的患眼年变化率低于-1.0 dB,属快速进展。
  • 29.0%的患眼MTD10年变化率低于-0.5 dB,中心视野丢失明显。
  • 约八分之一的患眼在常规诊疗下仍表现为整体视野快速进展。

核心结论

  • 在常规诊疗的青光眼患眼中,约八分之一基于整体MD值表现为快速进展(<-1.0 dB/年),近三分之一中心MTD10年下降超过0.5 dB。
  • 作者认为这些发现凸显评估中心视野进行性丢失的临床重要性,并强调需要新疗法以防止相当比例持续快速进展者的功能残疾。

研究设计与样本

  • 观察性研究,纳入澳大利亚墨尔本一家私人眼科诊所的患者及美国3个中心2项前瞻性纵向观察研究的个体。
  • 共纳入461例个体的693只患眼,随访中位数4.5年;所有个体均有青光眼诊断、接受常规诊疗,并在1至5年内完成5次及以上可靠的24-2视野检查。
  • 采用普通最小二乘回归分析计算每只眼整体MD随时间的变化速率及中心10°区域内12个测试点平均总偏差(MTD10)的变化速率。

主要发现

  • 基于MD,12.5%的患眼年变化率低于-1.0 dB/年;基于MTD10,11.7%的患眼年变化率低于-1.0 dB/年。
  • 29.0%的患眼MTD10年变化率低于-0.5 dB/年。
  • 分别有12.7%和9.1%的患眼MD与MTD10年变化率超过估计正态分布(由正斜率估计)的1% cut-off。

临床怎么用

  • 原文结论强调评估中心视野进行性丢失的临床重要性,并强调需要新疗法以防止相当比例持续快速进展者的功能残疾;原文未据此给出具体诊疗推荐。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine the prevalence of fast global and central visual field (VF) progression in individuals with glaucoma under routine care. DESIGN: Observational study. PARTICIPANTS: Six hundred ninety-three eyes of 461 individuals with glaucoma followed up over a median of 4.5 years. METHODS: This study included (1) patients at a private ophthalmology clinic in Melbourne, Australia, and (2) individuals in 2 prospective longitudinal observational studies across 3 sites in the United States. All individuals had a diagnosis of glaucoma and were under routine care, and had performed 5 or more reliable 24-2 VF tests over a 1- to 5-year period. Ordinary least squares regression analyses were used to calculate the rate of global mean deviation (MD) change over time and the rate of the mean total deviation values of the 12 test locations within the central 10° region (MTD10) for each eye. MAIN OUTCOME MEASURES: Prevalence of progression based on the rate of MD and the MTD10 change across various fixed cutoffs and cutoffs based on the estimated normal distribution (from the positive slopes). RESULTS: Based on the MD and the MTD10, 12.5% and 11.7% of the eyes, respectively, exhibited a rate of change that was less than -1.0 dB/year (being a rate that typically is defined as "fast progression" for MD values), and 29.0% of the eyes showed a change of less than -0.5 dB/year on MTD10. Furthermore, 12.7% and 9.1% of the eyes exhibited a rate of change that exceeded the 1% cutoff of the estimated normal distribution MD and the MTD10 values, respectively. CONCLUSIONS: This study found that approximately 1 in 8 eyes with glaucoma receiving routine care showed fast progression based on global MD values (< -1.0 dB/year) and that nearly 1 in 3 eyes showed a < -0.5 dB/year decline centrally. These findings highlight the clinical importance of assessing progressive central VF loss and reinforce the need for new therapies to prevent functional disability in a notable proportion of individuals who continue to exhibit fast progression. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Jackson AB, Martin KR, Coote MA, et al. Fast Progressors in Glaucoma: Prevalence Based on Global and Central Visual Field Loss. Ophthalmology. 2023. PMID: 36693593. doi:10.1016/j.ophtha.2023.01.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。